The Labors Of Califf

The US FDA Commissioner nominee Robert Califf has so far promised to revamp FDA’s opioids policy, stay away from industry after leaving the agency, and clean up Accelerated Approval in 30 days. What other tasks will Democratic Senators demand before granting him confirmation?

Labors of Califf
Will Califf Be Able to Complete His Final Confirmation Labors? • Source: Nielsen Hobbs; the Pink Sheet | Alamy images

In Greek mythology, Hercules had to perform twelve seemingly impossible tasks to atone for murders committed in a fit of madness.

US FDA Commissioner nominee Robert Califf has nothing to atone for – but Senate Democrats apparently feel he needs to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Pink Sheet

Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

 

The Health and Human Services Secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

Clinical Trial Diversity Action Plan Guidance Must Return To US FDA Website, Court Says

 
• By 

HHS and its agencies violated the law by swiftly implementing “sweeping and poorly thought-through directives that ordered the bulk removal of healthcare resources,” including FDA draft guidances on diversity action plans and sex differences in clinical trials, a federal court said.

Industry Groups Back EU Life Sciences Strategy As Commission Pledges Clinical Trial Investment

 

Industry associations EFPIA, EUCOPE and EURORDIS have praised the European Commission’s newly launched life sciences strategy, which will see investment funnelled into improving the clinical trial ecosystem and supporting advanced therapy development.